focu list chang
say
re-acceler growth upgrad outperform neutral rais estim tp
power enterpris disrupt initi coverag outperform rate target price
well expect inclus alreadi price
time select buy smartphon chain
idea engin seri star boom china biotech market initi coverag outperform rate tp
better profit strong life gain rais estim target price
result op guidanc look safe around
introduc share buyback target dividend pay-out ratio next plan
neg share buy-back guidanc call flat growth
analyst disclosur credit suiss seek busi compani cover research
report result investor awar firm may conflict interest could affect
object report investor consid report singl factor make invest
say
feedback market key issu client length cycl core view client spoken
recent week across europ north america sharp slowdown global growth late
first half
re-acceler growth upgrad outperform neutral rais estim tp
increas forecast earn increas target price upgrad rate outperform
neutral forecast acceler organ growth driven market share gain oil price
remain elev product launch household bioag weaker comp ag feed
power enterpris disrupt initi coverag outperform rate target price
initi coverag pivot softwar outperform rate target price believ compani
pois benefit unpreced digit disrupt current face enterpris
follow releas result manag incommunicado invest commun
symantec held confer call afternoon includ ceo greg clark cfo nick noviello
main take-away symc anticip materi advers impact financi pend investig
well expect inclus alreadi price
includ china larg cap share emerg market use inclus
process begin june inclus factor iif appli june august
respect final list announc may earli morn hkt
would like receiv product pleas call product market london
time select buy smartphon chain
make small revis global smartphon estim forecast unit declin
previou estim flat modestli grow similar percentag asp assumpt remain larg
unchang kept unit shipment estim larg flat shift product mix
idea engin seri star boom china biotech market initi coverag outperform rate tp
initi beigen outperform tp potenti upsid beigen strong pipelin
two lead product btk inhibitor antibodi launch china us
forecast target nda submiss would major catalyst compani near term
met qingdao haier manag recent comfort bullish view compani
manag see sale momentum continu haier strateg focu high end product channel
restructur definit help sustain high growth
better profit strong life gain rais estim target price
fubon fhc host analyst meet review net profit nt yoy track ahead
origin mainli boost much higher life profit
result op guidanc look safe around
impress posit loss alreadi factor full-year op figur yoy includ gain
transfer wako pure chemic industri least consensu forecast bloomberg
around guidanc think compani got good start
introduc share buyback target dividend pay-out ratio next plan
posit impress sharehold return smfg brought forward expect dp increas
part capit polici updat introduc share buyback flexibl basi first one
announc buy-back
would like receiv product pleas call product market london
neg share buy-back guidanc call flat growth
impress mitsubishi estat earn target capit polici neg unlik mitsui fudosan
mitsubishi estat announc share buy-back guidanc call flat yoy growth op np
direct exposur malaysia australia inc small broad market level signific individu stock
ansel manufactur product malaysia anz own stake ambank healthscop patholog
busi malaysia contribut group ebitda risk premia set fall malaysia reform
headlin price previou day close unless otherwis note
compani mention price may
would like receiv product pleas call product market london
